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Summary. Photodynarnic therapy (PDT) is a clinically 
approved treatment for the ocular condition age-related 
macular degeneration, and certain types of cancer. PDT 
is also under investigation for other ocular, as well as, 
immune-mediated and cardiovascular indications. PDT 
is a two step procedure. In the first step, the 
photosensitizer, usually a porphyrin derivative, is 
administered and taken up by cells. The second step 
involves activation of the photosensitizer with a specific 
wavelength of visible light. Exposure to light of an 
activating wavelength generates reactive oxygen species 
within cells containing photosensitizer. PDT with 
porphyrin photosensitizers induces rapid apoptotic cell 
death, an event which may be attributed to the close 
association of these compounds with mitochondria. 
Thus, PDT is an attractive method to treat ailments such 
as cancer, vira1 infections, autoimmune disorders and 
certain cardiovascular diseases in which the apoptotic 
program may be compromised. The present review 
examines the cellular events triggered at lethal and 
sublethal PDT doses and their relationship to the 
subsequent effects exerted upon cells. 
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lntroduction 
The original use of photosensitizers for the treatment 
of disease dates back to ancient times when certain plant 
extracts were used to treat psoriasis and vitiligo 
(McCaughan, 1999; Kalka et al., 2000). Photodynamic 
therapy (PDT) is now an approved treatment for severa1 
types of cancer and recently gained approval for the 
treatment of age-related macular degeneration (AMD), 
the leading cause of blindness in the elderly. 
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was the first approved photosensitizer and is currently 
used clinically for the treatment of different forms of 
cancer (lung, esophageal, cervical, bladder, gastric) in 
North America, Europe and Japan. More recently, a 
major milestone in the field of ophthalmology was 
achieved when PDT gained regulatory approval in 
multiple jurisdictions for the use of Visudyne 
(benzoporphyrin derivative monoacid ring A, 
verteporfin, QLT Inc., Vancouver, BC) for the treatment 
of "wet" AMD, the leading cause of blindness among 
people over the age of 50. In the treatment of AMD, red 
laser light is directed into the eye shortly after the 
systemic administration of Visudyne (Bressler, 1999). 
The abnormal blood vessels responsible for the loss of 
visual acuity in this condition rapidly take up Visudyne 
and are destroyed upon light irradiation, most likely due 
to a combination of PDT-induced endothelial cell 
apoptosis, vaso-occlusion and thrombosis. In summary, 
Visudyne therapy of subfoveal choroidal neo- 
vascularization (CNV) from AMD was shown to safely 
reduce the risk of vision loss in patients with 
predominantly classic CNV from AMD (Bressler, 1999). 
In addition, Visudyne is being assessed for its abiiity to 
alleviate CNV not related to AMD, including pathologic 
myopia, ocular histoplasmosis, angioid streaks, and 
idiopathic causes (Sickenberg et al., 2000). 
PDT is a two-step procedure requiring 3 elements: 
photosensitizer, light and oxygen (Dougherty et al., 
1998). In the first step, a photosensitising agent (usually 
a porphyrin derivative) is administered intravenously 
(Fig. 1). The photosensitizer then circulates and 
accumulates in most cells, including the cells of interest. 
In the next step, the photosensitizer is exposed to non- 
thermal light of a specific wavelength which 'activates' 
the drug (Levy, 1995; Moore et al., 1997; Bressler and 
Bressler, 2000). According to the application, a specific 
light delivery source may be required. n p i c a l  light 
sources include light emitting diodes (LED), fluorescent 
tubes, or lasers for greater speciñcity. The initiating step 
of photosensitization is the absorption of a light photon 
by the photosensitizer elevating the molecule from its 
energy ground state to a highly unstable excited singlet 
state. The excited singlet phtotosensitizer either returns 
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to ground state, resulting in the emission of fluorescence, 
or undergoes an intersystem crossover to a longer lived 
triplet excited state (Henderson and Dougherty, 1992; 
Sternberg and Dolphin, 1996; Dougherty et al., 1998; 
Kalka et al., 2000). The interaction of this triplet 
photosensitizer with surrounding molecules results in 
two possible types of photo-oxidative events denoted 
5 p e  1 and Q p e  11 reactions. The products arising from 
the energised photosensitizer reacting with oxygen are 
peroxides, superoxide ions, and hydroxyl ions for v p e  1 
reactions and singlet oxygen (lo2) for 5 p e  11 reactions 
(Henderson and Dougherty, 1992;  Sternberg and 
Dolphin, 1996; Dougherty et al., 1998; Kalka et al., 
2000). Although both reactions may proceed 
simultaneously, the generation of lo2 via the Q p e  11 
pathway is believed to be primarily responsible for PDT- 
induced cytotoxicity because of its dynamic interaction 
with various biomolecules (Gomer et al., 1989; 
Henderson and Dougherty, 1992; Kalka et al., 2000). 
The anti-cancer action of PDT is likely two-fold: (1) 
as a consequence of direct photodynamic killing of 
tumour cells, and (2) vascular impairment that restricts 
blood supply to the region (Dougherty et al., 1998; 
Engbrecht e t  al., 1999). In the absence of light, 
photosensitizers have little discernible biological 
activity. Thus, PDT is advantageous in that light may be 
directed specifically at the target area, limiting the 
degree of unwanted side effects in non-target tissues. 
Cell shrinkage, cytoplasmic condensation, pyknotic 
nuclear chromatin, membrane blebbing and DNA 
fragmentation are hallmarks of apoptosis (Granville et 
al., 1998a). During the final stages of apoptosis, 
apoptotic cells become convoluted and separates into 
membrane-bound vesicles containing intact organelles 
and nuclear fragments (Granville et al., 1998a). 
Apoptotic debris is cleared by macrophages or other 
neighbouring cells (Granville et al., 1998a). PDT is a 
potent inducer of apoptosis in numerous experimental 
settings. Apoptosis has been detected in mouse tumours 
(Zaidi et al., 1993; Woodburn et al., 1997) as well as 
inflammatory cells associated with the synovial tissue of 
arthritic rabbits treated with PDT (Ratkay et al., 1998). 
In PDT-treated human sarcoma xenografts transplanted 
into nude mice, the mechanism of tumor destruction in 
this model appears to be vascular damage with initial 
apoptosis in tumor endothelial cells and delayed tumor 
cell apoptosis (Engbrecht et al., 1999). 
In addition to ocular disorders and cancer, PDT is 
under investigation for the treatment of atherosclerosis, 
restenosis, allograft rejection, and immune disorders 
(LaMuraglia et al., 1994, 1995; Sluiter et al., 1996; 
Obochi et al., 1997; Hunt and Chan, 1999b; Sessler and 
Miller, 2000). For the treatment of immune disorders 
such as psoriasis, the systemic delivery of photo- 
sensitizer is followed by broad exposure of a large 
surface area of the patient to activating light. Low, 
sublethal levels of PDT can modify immune responses 
while limiting skin inflammation or  erythema 
(Chowdhary et al., 1994; Leong et al., 1996; Sirnkin et 
al., 1997). Large populations of infiltrating T cells are 
present within the skin plaques of psoriatic patients (Bos 
and De Rie, 1999). Although the mechanisms by which 
PDT acts to alleviate psoriasis are not known, PDT may 
either have a direct impact on psoriatic keratinocytes, or 
may act indirectly by inducing apoptosis of plaque- 
associated T cells that release cytokines that alter 
keratinocyte growth and differentiation in this disease. 
To this extent, activated T cells are more susceptible to 
PDT-induced apoptosis than resting T cells (Hunt et al., 
1999a). Likely, the effects of PDT on psoriasis include 
both keratinocytes and T cells. 
Understanding of the biochemical mechanisms of 
PDT-induced apoptosis has advanced signifícantly over 
the past decade. PDT-induced apoptosis has been 
demonstrated using both in vitro and in vivo models. 
Further, PDT has the capacity to induce apoptosis in 
most normal and tumour cell types. The mitochondrial 
localization of certain second generation porphyrin 
derivatives permits rapid activation of the apoptotic 
program following photosensitization. The present 
review highlights recent advances in delineating the 
biochemical mechanisms of porphyrin-based PDT- 
lrradiaíion with 
non-thermal light 
ModiRcation of cell funciion 
andlor induction of 
cell death Fig. 1. PDT is a two-step procedure. In the first 
step, a photosensitizing agent is adrninistered. 
This is followed by an intewal in which the drug 
circulates within the blood and accurnulates 
within the target cells. In the second step, the 
photosensitizer is exposed to non-thermal light at 
a speclfic wavelength that "activates" the drug. 
Photosensitizer-containing cells can undergo 
rapid apoptotic cell death following exposure to 
an activating wavelength of light. 
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induced apoptosis. In addition, we will discuss the 
cellular signalling events associated with the much less 
understood sublethal effects of PDT. 
Mitochondrial regulation of PDT-induced apoptosis 
In addition to acting as the main site of cellular ATP 
production, mitochondria may also act as gatekeepers 
between life and cell death (Green and Reed, 1998). 
Since the initial observation that Bcl-2 inhibits apoptosis 
by preventing mitochondrial cytochrome c (cyt c) release 
(Kluck et al., 1997; Yang et al., 1997), the role of 
mitochondria in apoptosis has been the subject of intense 
research. Thus, the search for chemical agents that target 
mitochondria to induce apoptosis has gained much 
attention in recent years. Porphyrin-derived photo- 
sensitizers may localise to mitochondria (Kessel et al., 
1997; Kessel and Luo, 1999). In addition, a number of 
groups have now shown that cyt c is released into the 
cytosol immediately following photosensitisation using 
different photosensitisers (Granville et al., 1998b, 1999b; 
Vantieghem et al., 1998; Carthy et al., 1999; Inanami et 
al., 1999; Kessel and Luo, 1999; Varnes et al., 1999). 
Further evidence for a direct effect of certain 
photosensitisers, such as verteporfin, on mitochondria 
stems from the observation that unmasking of the 
apoptosis-associated mitochondrial 7A6 antigen occurs 
immediately after photosensitization and in parallel with 
the release of cyt c in PDT-treated HeLa ceils (Carthy et 
al., 1999). Although it has been demonstrated that the 
7A6 antigen is detected in apoptotic but not in healthy 
cells (Zhang et al., 1996), the role of this 38 kDa 
mitochondrial antigen is not understood. A detailed 
description of intracellular apoptotic events associated 
with PDT are illustrated in Fig. 2. 
Porphyrin-derived photosensitizers can bind 
mitochondrial peripheral-type benzodiazepine receptors 
(PBR) (Snyder et al., 1987; Verma and Snyder, 1988; 
Verma et al., 1998). PBR are located at the junction of 
the inner and outer mitochondrial membranes (Anholt et 
al., 1986; McEnery et al., 1992), a pivotal site for the 
integration of apoptosis-related signais (Kroemer et al., 
1997). Interestingly, PBR expression levels correlated 
with cell sensitivity to photodynamic killing with 
porphyrins (Verma et al., 1998). Thus, the locaiization of 
porphyrin-derived photosensitizers to mitochondria 
indicates how PDT with porphyrin photosensitizers may 
be capable of inducing rapid cyt c release and initiation 
of the apoptotic cascade. Identification of other mito- 
chondrial structures that bind porphyrin photosensitizers 
will be a future area of keen interest. 
Role of caspases in PDT-induced apoptosis 
Mitochondrial release of cyt c triggers a cascade of 
activities resulting in the activation of a family of 
proteases known as caspases (cysteinyl aspartate specific 
proteases). These enzymes define a group of cysteine 
proteases comprising a multi-gene family of which more 
than a dozen different mammalian members have been 
identified (Nicholson, 1999). Caspases reside within 
cells as inactive zymogens. The apoptotic program is 
amplified through a cascade of caspase activity. 
Caspases are believed to account for the majority of 
cellular and morphological events that occur during 
apoptosis by their cleavage of specific cellular proteins 
Flg. 2. PDT with porphyrin-derived photo- 
sensitizers can induce rapid apoptosis due to 
their close association with mitochondria. 
Following light actwation of the photosensitizer, 
cyt c is released immediately from mitochondria 
into the cytosol. Cytosolic cyt c, in combination 
with ATP and Apaf-1 are believed to facilitate the 
activation of caspase-9. Caspase-9 can initiate 
the activation of downstream 'executioner' 
caspases (Caspase-3, -6, -7). CaspaseJ can 
also process caspase-8, which may act to 
enhance cyt c release by cleaving Bid into a 
+-A 
truncated form (tBid) that is capable of initiating 
mitochondrial cyt c release. Executioner 
C Altered cell caspases are believed to be responsible for the 
cleavage of specific structural, signalling and 
/ reparative proteins that are responsible for the 
manifestation of the apoptoüc phenotype. Other 
proapoptotic signals such as increased 
intracellular Ca2+ and JNK acüvation have also 
been o b s e ~ e d ,  however, their role in PDT- 
induced apoptosis is unknown. Cellular 
redistribution of Bax may also amplify cyt c 
CApdependent Disniption Of release in certain cell types during PDT-induced 
-ladon DNA rewir DNA fragmentation apoptosis. 
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with structural, signalling, reparative or enzymatic 
function (Nicholson, 1999). Caspases recognize a 
specific tetrapeptide sequence within their target 
substrates. These amino acid motifs form the basis for 
inhibitor and synthetic substrate design (Nicholson, 
1999). Inhibition of caspase activity prevents many of 
the biochemical and morphological events that occur 
during apoptosis (Nicholson, 1999; Zheng et al., 1999). 
To date, approximately 70 different caspase substrates 
have been identified (Nicholson, 1999). One of the 
hallmarks of apoptotic death is genomic disassembly and 
DNA fragmentation. Caspases disrupt normal DNA 
repair processes by proteolytically cleaving and 
inactivating at least two key proteins involved in the 
maintenance of genomic integrity, poly (ADP-ribose) 
polymerase (PARP) and DNA dependent protein kinase 
(DNA-PK). Simultaneously, caspases provoke the onset 
of DNA fragmentation by indirectly activating an 
apoptosis-specific endonuclease (caspase activated 
deoxyribonuclease, CAD) by cleavage of its cognate 
inhibitory peptide (inhibitor of CAD, ICADIDNA 
fragmentation factor, DFF) (Nicholson, 1999). In PDT- 
induced apoptosis, caspase-dependent cleavage of PARP, 
DNA-PK and DFF have been observed (Granville et al., 
1997, 1998~). 
Although multiple caspases are active during 
apoptosis and possibly redundant in different cell types, 
lessons obtained from caspase knockout mice indicate 
that certain caspases are essential for the normal 
functioning and development of specific tissues (Zheng 
et al., 1999). For instance, caspases -3 and -6 are critica1 
for proper neurona1 development, while caspase-8 is 
necessary in cardiac development and erythropoiesis 
(Zheng et al., 1999). Caspase-2, on the other hand, has 
two isoforms, c a s p a s e - 2 ~  and caspase -2~ ,  which 
promote or inhibit apoptosis, respectively (Zheng et al., 
1999). Thus, deletion of this gene had differential 
positive and negative effects in a tissue-specific pattern 
(Zheng et al., 1999). For a more detailed description of 
the different caspase knockout mice, Zheng et al. (1999) 
recently published an extensive review outlining the 
phenotypes of different caspase knockout mice. 
Following the release of mitochondrial cyt c into the 
cytosol, activation of caspases-2, -3, -6, -7, -8, and -9 has 
been described for severa1 cell types treated with PDT 
(Granville et al., 1998b, 1999b, 2000; Carthy et al., 
1999). During receptor-mediated apoptosis, caspase-8 is 
mobilized prior to cyt c release. However, in PDT- 
induced apoptosis caspase-8 is activated after cyt c 
release in both normal and transformed cell types during 
PDT-induced apoptosis (Granville et al., 1998b, 1999b), 
an event likely triggered by caspase-3 (Granville et al., 
1998b). The later activation of caspase-8 during PDT- 
induced apoptosis may amplify cyt c release through 
caspase-8 mediated cleavage of Bid into a truncated 
form (tBid) that can cause cyt c release (Granville et al., 
1998b, 1999b; Slee et al., 1999, 2000). In addition, 
recent studies sugested that caspase-3 catalyzes Bid 
cleavage and triggers an amplification loop by which 
tBid induces further cyt c release (Slee et al., 2000). 
Role of Bcl-2 related proteins in the regulation of 
PDT-induced cell death 
The Bcl-2 proto-oncogene was initially discovered 
as a highly expressed protein in human B-cell 
lymphomas arising from a t(14;18) chromosomal 
translocation (Pegoraro et al., 1984; Tsujimoto et al., 
1985). Bcl-2 was subsequently found to promote the 
survival of many cell types exposed to a diverse range of 
pro-apoptotic stimuli including chemotherapeutics, 
viruses, hypoxia and ionising radiation (Reed, 1997, 
1998a,b). Since then, a number of pro-apoptotic (Bax, 
Bid, Bak, Bik, Bad, Bcl-XS, Bim, Bok) as well as anti- 
apoptotic (Bcl-2, Bcl-XL, Al ,  Bcl-w, Mcl-1) Bcl-2 
family members have been identified. Bcl-2 m-localizes 
to the outer membranes of mitochondria, endoplasmic 
reticuli (ER) and nuclei. Since the discovery that Bcl-2 
inhibits mitochondrial cyt c release (Kluck et al., 1997; 
Yang et al., 1997), the relationship between Bcl-2 and 
rnitochondria has been an area of great interest. 
Conflicting reports have been forwarded concerning 
the role of Bcl-2 and related proteins in PDT-induced 
apoptosis. Bcl-2 expression in Chinese hamster ovary 
cells inhibited apoptosis and partially protected against a 
loss of clonogenicity in Pc4-based PDT (He et al., 1996), 
while in breast epithelial cells Bcl-2 promotes PDT- 
induced apoptosis using the photosensitizer PcAl (Kim 
et al., 1999). The increased susceptibility of Bcl-2 over- 
expressing cells to PDT was believed to be due to a 
photodynamic destruction of Bcl-2 that allowed Bax to 
exert its pro-apoptotic activity (Kim et al., 1999). 
Conversely, Bcl-2 or Bcl-X over-expression in HL-60 
cells suppressed verteporEn-kased PDT-induced caspase 
activation and DNA fragmentation (Granville et al., 
1998c, 1999a). Bcl-XL overexpression inhibited DNA 
fragmentation indirectly by suppressing caspase-3 
activity and subsequent DFF cleavage after PDT 
(Granville et al., 1998~).  However, Bcl-2/XL does not 
appear to prevent PDT-mediated mitochondrial 
alterations. In fact, over-expression of Bcl-2 or Bcl-X 
in HeLa cells did not prevent the release 04 
mitochondrial cyt c, the unmasking of the mitochondrial 
7A6 antigen or cell death induced by PDT with 
verteporñn (Carthy et al., 1999). Furthermore, studies of 
hypericin-based PDT indicated that human glioma cell 
viability was unrelated to expression levels of Bcl-2 or 
Bax (Weller et al., 1997). In summary, the role of Bcl-2 
and related anti-apoptotic proteins in the regulation of 
PDT-induced apoptosis is unclear but these proteins may 
act in a cell type- and photosensitizer-specific manner. 
The status of pro-apoptotic Bcl-2 family members 
has been assessed for normal and transformed cell types 
treated with PDT. Treatment of human umbilical venous 
endothelial cells (HUVEC) with verteporfin-based PDT 
induced cleavage of the Bcl-2 homologue Bid into its 
pro-apoptotic tBid form (Granville et al., 1999b). 
However, in contrast to receptor-mediated forms of 
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apoptosis, Bid cleavage occurred downstream of 
mitochondrial cyt c release (Granville et al., 1999b). 
Since Bid is a caspase-8 and caspase-3 substrate (Li et 
al., 1998; Luo et al., 1998; Slee et al., 2000) and both are 
activated downstream of cyt c release following PDT 
(Granville et al., 1999b), it is possible that caspase- 
mediated Bid cleavage may amplify cyt c release in 
certain PDT-treated cell types. 
Cellular redistribution of Bax from the cytosol to 
mitochondria may also enhance cyt c release after PDT 
in normal, but not transformed cell types. In primary 
HUVEC, cytosolic Bax levels gradually decreased 
following PDT (Granville et al., 1999b) but were 
unchanged in HeLa cells undergoing PDT-induced 
apoptosis (Carthy et al., 1999). The explanation for this 
difference is unclear. Further, cytosolic cyt c levels 
increase over 2 h in PDT-treated HUVEC, but not in 
PDT-treated HeLa cells (Carthy et al., 1999; Granville et 
al., 1999b). Many tumour cell types are known to 
contain abnormal expression or mutations in one or more 
Bcl-2-related genes (Reed et al., 1996; Reed, 1998a,b). 
Therefore, it is possible that pro-apoptotic Bax-mediated 
signalling pathways may have been impaired in the 
transformed HeLa cell line that was used for these 
experiments. Thus, it is possible that in PDT-treated non- 
transformed cells that immediate cyt c release is 
attributed to direct mitochondrial effects while further 
cyt c release is a result of Bax andlor Bid-mediated 
activity. 
Effects of PDT on intracellular calcium regulation 
The impact of PDT on ER integrity and intracellular 
calcium regulation are poorly understood. Evidence 
suggesting a role for ER in PDT-induced apoptosis stems 
from studies demonstrating capase-8 mediated cleavage 
of the integral ER Bap31 protein in HeLa cells treated 
with verteporfin and light (Granville et al., 1998b). 
Furthermore, certain porphyrin photosensitizers 
(haematoporphyrin, HP and protoporphin IX, PPIX) 
associate with ER to a greater degree than mitochondria 
in rat liver cells (Ricchelli et al., 1999 . With these 2 photosensitizers, altered intracellular Ca + levels were 
mediated as a consequence of PDT-mediated ER damage 
as opposed to mitochondrial dama e (Ricchelli et al., 
1999). In support of a role of Ca5+ in PDT-induced 
apoptosis, for pheophorbide-treated Chinese hamster 
V79 cells, the intracellular calcium chelator BAPTA-AM 
inhibited cyt c release, caspase-3 activation and 
apoptosis following light activation (Inanami et al., 
1999). Thus, in this system, the PDT-induced increase in 
intracellular ca2+ levels may instigate mitochondrial cyt 
c release. It has not been determined whether BAPTA- 
AM would prevent cyt c release induced by PDT using 
other photosensitizers. 
PDT, cell signalling and apoptosis 
The role of protein kinases in the regulation of cell 
death and survival is unclear. However, their 
involvement in the regulation of cell death and survival 
has been described in recent years. Although protein 
phosphorylation and kinase activation have been 
described for PDT-treated cells Oao et al., 1996; Xue et 
al., 1997, 1999a,b; Granville et al., 1998d; Klotz et al., 
1998; Assefa et al., 1999), their inluence on cell death 
andlor cell survival signalling pathways is unresolved. 
The non-receptor tyrosine kinase Etk provided a degree 
of protection against PDT-induced apoptosis with Pc4 in 
prostate cancer cells (Xue et al., 1999b). Increased 
activity of stress-activated protein kinase (SAPK)/c-jun 
NH2-terminal kinase (JNK) and p38 high osmolarity 
glycerol protein kinase 1 (p38), in mouse (Tao et al., 
1996) and human keratinocytes (Klotz et al., 1998) has 
been demonstrated. The significance of these events in 
relationship to cell death or cell survival in PDT-treated 
cells is yet unclear. However, a recent study by Davis 
and colleagues suggests a requirement for SAPWJNK in 
triggering cyt c release in UV-induced apoptosis in 
murine embryonic fibroblasts (Toumier et al., 2000). A 
role for SAPWJNK in Fas-induced apoptosis has also 
been described (Costa-Pereira et al., 2000). Hypericin- 
based PDT activated SAPWJNK while irreversibly 
inhibiting extracellularly-regulated kinase-1 (ERK1) 
activity in tumour cells (Assefa et al., 1999). This latter 
report also indicated that PDT-induced activation of 
SAPKJJNK was caspase independent (Assefa et al., 
1999). Inhibition of p38 kinase activity impaired Pc4 
mediated PDT-induced apoptosis in LY-R cells but did 
not affect PDT-induced apoptosis for Chinese hamster 
ovary ceiis (Xue et al., 1999a,b). By contrast, inhibition 
of p38 promoted apoptosis for HeLa cells treated with 
hypericin-based PDT (Assefa et al., 1999). PDT-induced 
apoptosis was enhanced by expression of the dual 
specificity MKP-1 phosphatase (Assefa et al., 1999). 
The apparent differential activities of MAP kinases 
during PDT-induced apoptosis may be attributable to the 
cell type, the photosensitizer used andlor the intensity of 
light applied. Clearly, the role of kinases in PDT-induced 
apoptosis requires further resolution. 
Transcriptional regulators 
Nuclear factor-kappaB (NF-KB) DNA binding 
activity occurs in response to various stimuli including 
cytokines, vira1 infection, phorbol esters, oxidants or 
radiation (Karin, 1998). NF-KB is not a single protein, 
but is comprised of dimers of Re1 family DNA binding 
proteins that bind closely related NF-KB recognition 
motifs (Karin, 1998). NF-KB resides in the cytoplasm in 
an inactive state in association with inhibitory KB (IKB) 
proteins (Karin, 1998). Upon activation, via degradation 
of IKB, NF-KB translocates to the nucleus where it 
activates the transcription of a variety of genes involved 
in immune and inflammatory responses (Karin, 1998). 
photofrinB based PDT induced NF-KB nuclear 
translocation in murine L1210 lymphoma cells (Ryter 
and Gomer, 1993) as well as increased c-fos and c-jun 
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gene expression (Kick et al., 1996). The c-fos 
heterodimerises with c-jun to form the AP-1 
transcription factor. In HeLa cells treated with 
~hotofrin@-based PDT, activation of AP-1 but not NF- 
KB was observed (Kick et al., 1995). With verteporñn, as 
well as pyropheophorbide-a methyl ester (PPME) based 
PDT, decreased IKBa levels and NF-KB activation were 
observed (Matroule et al., 1999; Granville et al., 2000). 
Furthermore, increased sensitivity to apoptosis was 
described for PDT (PPME)-treated HCT-116 carcinoma 
cells in which the NF-KB pathway was impaired due to 
an overexpression of an IKB super repressor protein 
suggesting that NF-KB influences cell sensitivity to PDT 
(Matroule et al., 1999a,b). 
In addition to its role in immune responses, NF-KB 
stimulates the transcription of pro-survival genes such as 
Al ,  A20, Bcl-XL, TNFR-associated factors 1 and 2 
(TRAF1 and 2) and inhibitor of apoptosis proteins 
(IAPs) (Wang et al., 1998; Lee et al., 1999; Zong et al., 
1999). Thus, it is possible that low-leve1 PDT rnay 
activate the NF-KB pathway and subsequent 
transcription of anti-apoptotic genes. Conversely, NF-KB 
could activate genes such as FasL, thereby stimulating a 
'counterattack' mechanism against cells expressing Fas 
(Kasibhatla et al., 1999). Such an effect on keratinocytes 
rnay be beneficia1 for the treatment of psoriasis with 
PDT in which high levels of pathogenic, infiltrating, Fas- 
positive T cells are present in the skin. 
The tumour suppressor gene p53 is involved in the 
regulation of cell division and cell death. Altered p53 
function or expression is associated with many forms of 
cancer and this rnay impact cell resistance to 
chemotherapy and y-irradiation. HL-60 p53 deficient 
cells were less sensitive to photofrinB based PDT than 
those transfected with wild type p53 (Fisher et al., 1997). 
This phenomenon rnay be explained by the observation 
that p53 gene expression can, in certain cell types, 
upregulate Bax expression while downregulating Bcl-2 
expression (Miyashita et al., 1994; Miyashita and Reed, 
1995; McCurrach et al., 1997; Budhram-Mahadeo et al., 
1999) which rnay account for the increased sensitivity of 
these cells to PDT. In further support of this concept, 
human colon cancer cell lines with a mutated p53 gene 
exhibited a greater sensitivity to PDT following 
transfection with wild type p53 (Zhang et al., 1999). 
Conversely, when p53 was specifically targeted for 
ubiquitin degradation in cells transfected with the E6 
viral oncogene, no change in tumour cell sensitivity to 
PDT with photofrinB was evident (Fisher et al., 1999). 
For a number of human glioma cell lines, susceptibility 
to PDT with hypencin was unrelated to p53 expression 
leve1 (Weller et al., 1997). Although in certain cases p53 
transfection rnay heighten cell sensitivity to PDT, the 
effect is most likely due to the restoration of p53- 
regulated apoptosis pathways since p53 null cells are 
still susceptible to PDT-induced apoptosis. 
Concluslon 
The emergence of PDT, a treatment that primarily 
affects cells containing drug exposed to activating light, 
provides severa1 advantages over standard systemic 
cytotoxic agents since its activity can be controlled by 
the degree and targeting of light. In addition, porphyrin- 
derived photosensitizers have the added benefit in that 
they rnay directly affect mitochondria to induce 
apoptosis. This property suggests that this form of 
treatment rnay circumvent anti-apoptotic mechanisms 
that are present in certain types of cancer, viral infection, 
or diseases in which immune-mediated apoptotic 
elimination of damaged, injured, or unwanted cells is 
hindered. Over the past few years, great advances have 
been made in the understanding of the biochemical 
pathways that are activated during PDT-induced 
apoptosis. However, further studies are necessary to 
delineate and understand the significance of signalling 
pathways that are activated in different cell types in 
response to sub-lethal levels of PDT. Additionally, it will 
be important to determine the characteristics that render 
certain cell types, such as activated T cells, more 
susceptible to PDT-induced apoptosis. With these recent 
advances in our understanding of PDT mechanisms, as 
well as the increasing approvals for the use of PDT to 
treat various types of disease, the advantages of this form 
of treatment are finally being recognised. This bodes 
well for further advances in the years ahead. 
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